Verbal learning and memory in youth with neurofibromatosis type 1 and plexiform neurofibromas: Relationships with disease severity.


Journal

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
ISSN: 1532-2130
Titre abrégé: Eur J Paediatr Neurol
Pays: England
ID NLM: 9715169

Informations de publication

Date de publication:
May 2022
Historique:
received: 27 07 2021
revised: 08 02 2022
accepted: 11 03 2022
pubmed: 26 3 2022
medline: 7 6 2022
entrez: 25 3 2022
Statut: ppublish

Résumé

To provide a comprehensive characterization of verbal learning and memory (VLM) abilities in youth with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PNs) and to evaluate disease severity as a predictor of VLM functioning over time. As part of a longitudinal natural history study, youth with NF1 and PNs were administered repeat neuropsychological assessments, including measures of VLM and ratings of NF1 disease severity completed by a medical professional. This sub-study analyzed data from 89 patients (M age VLM scores across the sample fell predominantly within the average range of functioning at both time points. However, relative to peers with mild NF1 disease severity, youth with moderate/severe NF1 disease showed lower functioning across multiple VLM domains at 36 months, even after controlling for the effects of verbal attention. Exclusive use of overall domain scores does not fully characterize VLM functioning in youth with NF1 and PNs. Additionally, children and adolescents with more severe NF1 disease should be monitored more closely for verbal memory challenges and targeted for interventions.

Identifiants

pubmed: 35334353
pii: S1090-3798(22)00039-3
doi: 10.1016/j.ejpn.2022.03.004
pmc: PMC10575344
mid: NIHMS1928069
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-12

Subventions

Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : Intramural NIH HHS
ID : ZID BC011517
Pays : United States

Informations de copyright

© 2022 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.

Références

J Child Neurol. 2008 Sep;23(9):1002-10
pubmed: 18827266
J Learn Disabil. 1997 Sep-Oct;30(5):521-33
pubmed: 9293234
J Int Neuropsychol Soc. 1997 Nov;3(6):608-16
pubmed: 9448374
Soc Sci Med. 1996 Jan;42(1):99-109
pubmed: 8745111
J Pediatr Psychol. 2012 Aug;37(7):713-24
pubmed: 22353803
Acad Emerg Med. 2005 Apr;12(4):360-5
pubmed: 15805329
Pain Med. 2015 Feb;16(2):367-73
pubmed: 25377441
Am J Pediatr Hematol Oncol. 1990 Summer;12(2):174-81
pubmed: 2116096
Brain Lang. 2003 Apr;85(1):125-39
pubmed: 12681352
J Pediatr. 2013 Nov;163(5):1479-83.e1
pubmed: 23910685
Dev Med Child Neurol. 2006 Dec;48(12):973-7
pubmed: 17109785
J Int Neuropsychol Soc. 1999 Jan;5(1):26-31
pubmed: 9989021
Dev Med Child Neurol. 2013 Feb;55(2):111-125
pubmed: 22934576
J Learn Disabil. 2003 May-Jun;36(3):259-69
pubmed: 15515646
J Int Neuropsychol Soc. 2010 Nov;16(6):1056-63
pubmed: 20682087
J Pediatr. 2011 Oct;159(4):652-5.e2
pubmed: 21621223
J Child Neurol. 2010 Oct;25(10):1195-202
pubmed: 20139412
Am J Med Genet A. 2015 Sep;167A(9):2103-13
pubmed: 25976979
Am J Med Genet. 2000 Summer;97(2):119-27
pubmed: 11180219
J Int Neuropsychol Soc. 2013 Sep;19(8):881-9
pubmed: 23790158
Neuroimage Clin. 2017 Jun 27;15:801-811
pubmed: 28725547
Neurology. 2007 Feb 27;68(9):643-7
pubmed: 17215493
J Neurol Sci. 1996 Jun;138(1-2):125-33
pubmed: 8791250
Dev Med Child Neurol. 2020 Aug;62(8):977-984
pubmed: 32052421
Neuropsychology. 2009 Jan;23(1):50-60
pubmed: 19210032
Am J Med Genet. 1999 Mar 26;89(1):45-52
pubmed: 10469436
Child Neuropsychol. 2001 Mar;7(1):15-20
pubmed: 11815877
J Pediatr Psychol. 2007 Oct;32(9):1127-39
pubmed: 17569711
Neurology. 2016 Aug 16;87(7 Suppl 1):S21-30
pubmed: 27527646
Am J Med Genet A. 2007 Oct 1;143A(19):2261-73
pubmed: 17726688
Child Neuropsychol. 2006 Jun;12(3):191-203
pubmed: 16837395
J Intellect Disabil Res. 2005 Jan;49(Pt 1):33-46
pubmed: 15634310
Arch Neurol. 1988 May;45(5):575-8
pubmed: 3128965
Birth Defects Orig Artic Ser. 1977;13(3C):131-8
pubmed: 407957

Auteurs

Caitlyn Loucas (C)

Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD, United States.

Pamela Wolters (P)

Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD, United States.

Mary Anne Toledo-Tamula (MA)

Clinical Research Directorate (CRD), Frederick National Laboratory for Cancer Research, United States.

Amanda Rhodes (A)

Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD, United States.

Andrea Baldwin (A)

Clinical Research Directorate (CRD), Frederick National Laboratory for Cancer Research, United States.

Anne Goodwin (A)

Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD, United States.

Brigitte Widemann (B)

Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD, United States.

Staci Martin (S)

Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD, United States. Electronic address: martins@mail.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH